We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Randomized trial reports comparative efficacy and safety outcomes of upadacitinib versus dupilumab in adults with atopic dermatitis, indicating distinct clinical profiles.
ClinicalTrials.gov Identifier: NCT03738397.
No takes yet. Share an insight, caveat, or question.
Blauvelt et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: